Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)
NCT01327222
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Age Related Macular Degeneration
Interventions
DRUG:
Bevacizumab
Sponsor
IRCCS San Raffaele